Abbott Laboratories (ABT) Land & Improvements (2009 - 2021)
Abbott Laboratories (ABT) posted Land & Improvements of $525.0 million for Q4 2021, down 2.42% sequentially from $538.0 million in Q4 2020, and down 2.42% YoY from $538.0 million in Q4 2020.
Abbott Laboratories (ABT) Land & Improvements (2009 - 2021) Analysis & Trends
Abbott Laboratories has reported Land & Improvements for 12 years, with the latest figure at $525.0 million in Q4 2021.
- Quarterly Land & Improvements fell 2.42% year-over-year to $525.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $525.0 million (down 2.42% YoY) and the FY2021 annual result came in at $525.0 million, down 2.42% from the prior year.
- Land & Improvements fell to $525.0 million in Q4 2021 per ABT's latest filing, from $538.0 million in the prior quarter.
- Over five years, Land & Improvements peaked at $538.0 million in Q4 2020 and troughed at $501.0 million in Q4 2018.
- A 5-year average of $521.8 million and a median of $525.0 million in 2021 frame the typical range for Land & Improvements.
- The sharpest annual moves came in 2017 and 2018: Land & Improvements increased 28.92% in 2017, then dropped 4.75% in 2018.
- Over 5 years, Land & Improvements stood at $526.0 million in 2017, then declined by 4.75% to $501.0 million in 2018, then rose by 3.59% to $519.0 million in 2019, then advanced by 3.66% to $538.0 million in 2020, then declined by 2.42% to $525.0 million in 2021.
- According to Business Quant data, Land & Improvements over the past three periods registered $525.0 million, $538.0 million, and $519.0 million for Q4 2021, Q4 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 1.81 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 183.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 112.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 525.00 Mn |
| Dec 31, 2020 | 538.00 Mn |
| Dec 31, 2019 | 519.00 Mn |
| Dec 31, 2018 | 501.00 Mn |
| Dec 31, 2017 | 526.00 Mn |
| Dec 31, 2016 | 408.00 Mn |
| Dec 31, 2015 | 432.00 Mn |
| Dec 31, 2013 | 502.00 Mn |
| Dec 31, 2012 | 605.00 Mn |
| Dec 31, 2011 | 633.92 Mn |
| Dec 31, 2010 | 648.99 Mn |
| Dec 31, 2009 | 546.20 Mn |